|
Survival after secondary liver resection in metastatic colorectal cancer: A comparative analysis of the LICC trial with historical controls (CELIM, FIRE-3). |
| |
|
No Relationships to Disclose |
| |
|
|
Consulting or Advisory Role - Baxalta; Bayer; Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER |
Research Funding - Merck KGaA |
| |
|
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical |
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst) |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical |
| |
|
|
Consulting or Advisory Role - Roche |
|
Travel, Accommodations, Expenses - Novartis; Roche |
| |
|
Patents, Royalties, Other Intellectual Property - patent |
| |
|
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER |
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Merck; Roche |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Astellas Pharma; Baxter; Integra LifeSciences; MCI Group; Medupdate; Merck Serono; Teva |
Consulting or Advisory Role - Astellas Pharma |
Speakers' Bureau - Integra LifeSciences |
| |
|
Consulting or Advisory Role - Roche |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Infomedica; Lilly; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER |
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme |
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Merck Serono (Inst) |
| |
Carl Christoph Schimanski |
|
Research Funding - Merck (Inst) |
Travel, Accommodations, Expenses - Gilead Sciences |